Chen Yang Luke Buys Shares of 111, Inc.

Chen Yang Luke purchased 54,759 shares of 111, Inc. on May 11, 2026.

Written by EarningsIQ · Published Jun 16, 2026, 7:00 AM EDT · Updated Jun 16, 2026, 3:00 PM EDT

Key Points

Chen Yang Luke acquired 54,759 shares of 111, Inc. on May 11, 2026.
111, Inc. trades on NasdaqGM under the ticker YI, with a market cap of $40.2 million.
Renaissance Technologies LLC and Serenus Wealth Advisors also adjusted their holdings in 111, Inc.

On May 11, 2026, Chen Yang Luke made a purchase of 54,759 shares of 111, Inc., trading on the NasdaqGM under the ticker YI. This transaction did not specify an average price or total transaction value.

Insider Buying and Selling at 111, Inc.

Chen Yang Luke's acquisition of 54,759 shares isn't the only recent insider activity. On June 15, 2026, Sun Jian David sold 58,800 shares, and Chen Yang Luke himself sold 44,000 shares on the same day, both at an average price of $0.23. Earlier, on June 12, Chen Yang Luke sold 49,920 shares at the same price.

Other Institutional Activity in 111, Inc.

Renaissance Technologies LLC increased its position in 111, Inc. by 300 shares, bringing its total to 13,014 shares valued at approximately $84,851. Serenus Wealth Advisors, LLC slightly reduced its stake by 64 shares, holding a total of 4,320 shares worth about $321,334. Meanwhile, Citigroup Inc. initiated a new position with 207 shares valued at $1,341.

111, Inc. Stock Snapshot

Shares of 111, Inc. are trading at around $4.57. The company has a market capitalization of approximately $40.2 million and a forward P/E ratio of 32.64. Its beta is 0.609, indicating lower volatility compared to the market. The stock's 52-week range is between $2.48 and $11.17, with a 50-day moving average of $5.88 and a 200-day moving average of $5.40.

Recent Earnings

111, Inc. reported revenue of about $11.39 billion, though it experienced a revenue decline of 33.1%. The company posted a net margin of -0.75% and a return on equity of -14.84%, reflecting ongoing financial challenges. Its next earnings announcement is expected on March 19, 2026.

About 111, Inc.

111, Inc. operates a comprehensive online and offline platform in China's healthcare sector, focusing on medical distribution. The company offers a range of services, including supply chain integration, product promotion, and online retail through its 1 Pharmacy and 1 Medicine Marketplace platforms. Headquartered in Shanghai, 111, Inc. is led by CEO Mr. Junling Liu and employs over 1,000 people.

Bottom Line

Chen Yang Luke's recent purchase of shares in 111, Inc. highlights ongoing interest in the company's stock. Although 111, Inc. faces financial challenges, its presence in the healthcare sector and recent institutional activity suggest a watchful eye on its performance. As always, it's important to remember that 13F filings and insider trades reflect past actions and may not indicate future trends.